Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas

K. T. Barker, S. Bevan, R. Wang, Y. J. Lu, A. M. Flanagan, J. A. Bridge, C. Fisher, C. J. Finlayson, J. Shipley, R. S. Houlston

Research output: Contribution to journalArticle

50 Scopus citations

Abstract

Germline mutations in the fumarate hydratase gene at 1q43 predispose to dominantly inherited skin and uterine leiomyomata and leiomyosarcomas. The enzyme, which is a component of the tricarboxylic acid cycle, acts as a tumour suppressor. To evaluate fumarate hydratase in respective sporadic tumours, we analysed a series of 26 leiomyosarcomas and 129 uterine leiomyomas (from 21 patients) for somatic mutations in fumarate hydratase and allelic imbalance around 1q43. None of the 26 leiomyosarcomas harboured somatic mutations in fumarate hydratase. Fifty per cent of leiomysarcomas tested showed evidence of allelic imbalance at 1q, but this was not confined to the vicinity of fumarate hydratase. Only 5% (seven out of 129) of the leiomyomas showed allele imbalance at 1q42-q43 and no somatic mutations in fumarate hydratase were observed. Our findings indicate that mutations in fumarate hydratase do not play a major role in the development of sporadic leiomyosarcomas or uterine leiomyomas.

Original languageEnglish (US)
Pages (from-to)446-448
Number of pages3
JournalBritish journal of cancer
Volume87
Issue number4
DOIs
Publication statusPublished - Jan 1 2002

    Fingerprint

Keywords

  • Fumarate hydratase
  • Leiomyomas
  • Leiomyosarcomas
  • Mutation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this